Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination.

BMJ open gastroenterology

Erikstrup LT, Aarup M, Hagemann-Madsen R, Dagnaes-Hansen F, Kristensen B, Olsen KE, Fuursted K.
PMID: 26568840
BMJ Open Gastroenterol. 2015 Nov 02;2(1):e000038. doi: 10.1136/bmjgast-2015-000038. eCollection 2015.

OBJECTIVE: Clostridium difficile is a major cause of nosocomial infectious diarrhoea. Treatment of C. difficile infection (CDI) depends on disease severity. A combination of vancomycin and metronidazole is often recommended in severe cases. The aim of this study was...

Cite
Erikstrup LT, Aarup M, Hagemann-Madsen R, et al. Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination. BMJ Open Gastroenterol. 2015;2(1):e000038doi: 10.1136/bmjgast-2015-000038.
Erikstrup, L. T., Aarup, M., Hagemann-Madsen, R., Dagnaes-Hansen, F., Kristensen, B., Olsen, K. E., & Fuursted, K. (2015). Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination. BMJ open gastroenterology, 2(1), e000038. https://doi.org/10.1136/bmjgast-2015-000038
Erikstrup, Lise Tornvig, et al. "Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination." BMJ open gastroenterology vol. 2,1 (2015): e000038. doi: https://doi.org/10.1136/bmjgast-2015-000038
Erikstrup LT, Aarup M, Hagemann-Madsen R, Dagnaes-Hansen F, Kristensen B, Olsen KE, Fuursted K. Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination. BMJ Open Gastroenterol. 2015 Nov 02;2(1):e000038. doi: 10.1136/bmjgast-2015-000038. eCollection 2015. PMID: 26568840; PMCID: PMC4641438.
Copy Download .nbib Format: NLM
Postoperative MRI Findings Following Conventional and Extralevator Abdominoperineal Excision in Low Rectal Cancer.

Frontiers in surgery

Oerskov KM, Bondeven P, Laurberg S, Hagemann-Madsen RH, Christensen HK, Lauridsen H, Pedersen BG.
PMID: 34869567
Front Surg. 2021 Nov 16;8:771107. doi: 10.3389/fsurg.2021.771107. eCollection 2021.

No abstract available.

Cite
Oerskov KM, Bondeven P, Laurberg S, et al. Postoperative MRI Findings Following Conventional and Extralevator Abdominoperineal Excision in Low Rectal Cancer. Front Surg. 2021;8:771107doi: 10.3389/fsurg.2021.771107.
Oerskov, K. M., Bondeven, P., Laurberg, S., Hagemann-Madsen, R. H., Christensen, H. K., Lauridsen, H., & Pedersen, B. G. (2021). Postoperative MRI Findings Following Conventional and Extralevator Abdominoperineal Excision in Low Rectal Cancer. Frontiers in surgery, 8771107. https://doi.org/10.3389/fsurg.2021.771107
Oerskov, Kim Morgenstjerne, et al. "Postoperative MRI Findings Following Conventional and Extralevator Abdominoperineal Excision in Low Rectal Cancer." Frontiers in surgery vol. 8 (2021): 771107. doi: https://doi.org/10.3389/fsurg.2021.771107
Oerskov KM, Bondeven P, Laurberg S, Hagemann-Madsen RH, Christensen HK, Lauridsen H, Pedersen BG. Postoperative MRI Findings Following Conventional and Extralevator Abdominoperineal Excision in Low Rectal Cancer. Front Surg. 2021 Nov 16;8:771107. doi: 10.3389/fsurg.2021.771107. eCollection 2021. PMID: 34869567; PMCID: PMC8635027.
Copy Download .nbib Format: NLM
The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries.

Clinical epidemiology

Ravn S, Christiansen CF, Hagemann-Madsen RH, Verwaal VJ, Iversen LH.
PMID: 32273772
Clin Epidemiol. 2020 Mar 27;12:333-343. doi: 10.2147/CLEP.S238193. eCollection 2020.

INTRODUCTION: Treatment options for peritoneal metastases (PM) from colorectal cancer (CRC) have increased, their efficiency should be monitored. For this purpose, register-based data on PM can be used, if valid.PURPOSE: We aimed to evaluate the completeness and positive predictive...

Cite
Ravn S, Christiansen CF, Hagemann-Madsen RH, et al. The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries. Clin Epidemiol. 2020;12:333-343doi: 10.2147/CLEP.S238193.
Ravn, S., Christiansen, C. F., Hagemann-Madsen, R. H., Verwaal, V. J., & Iversen, L. H. (2020). The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries. Clinical epidemiology, 12333-343. https://doi.org/10.2147/CLEP.S238193
Ravn, Sissel, et al. "The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries." Clinical epidemiology vol. 12 (2020): 333-343. doi: https://doi.org/10.2147/CLEP.S238193
Ravn S, Christiansen CF, Hagemann-Madsen RH, Verwaal VJ, Iversen LH. The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries. Clin Epidemiol. 2020 Mar 27;12:333-343. doi: 10.2147/CLEP.S238193. eCollection 2020. PMID: 32273772; PMCID: PMC7108706.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries